Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Hanover v2

No description
by

John Barlow

on 22 March 2017

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Hanover v2

During ACC2.8 million impressions from 291 Twitter
mentions of Amgen or Repatha from 184 users
Peak of 170 tweets at time of Fourier results
57% of tweets from those of high authority

Top hashtags associated with Amgen and Repatha at ACC
BRIEF-Regeneron and Sanofi to present new phase 3 praluent (alirocumab) injection clinical trial analyses at ACC.17 Scientific Sessions.
Praluent's cardiovascular benefit ral ODYSSEY is expected to read out in December 2017
On the one hand...
" 'Huge advance' in fighting world's biggest killer "
" Powerful new cholesterol drug helps statins slash the risk of heart attack: Medication could save thousands of lives every year "
" HEART ATTACK DRUGS BOOST New wonder drug can ' slash risk of heart attack, stroke or death by QUARTER ' compared with just statins "
" Mixing new drug with statins can reduce risk of heart attack "
On the other hand...
" Did Amgen's Repatha cut CV risks enough to make it cost-effective? Analysts say no "
Repatha outcomes data "less than stellar Analysts underwhelmed by latest results on Amgen's drug despite it seeing some improvements "
ACC topics
ACC Buzz cloud
Top topics associated with Amgen and Repatha at ACC
" New drug that can 'switch off' heart disease could cut death rates by a FIFTH "
Amgen cholesterol drug cuts heart attack, stroke risk but shares fall
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
A Heart Attack-Prevention Drug Disappoints...Wall Street
Hot on the heels...
In light of Fourier data, what future for Alnylam and TMC's PCSK9 inclisiran?
ACC hashtags
Welcome
Repatha reduced the risk of
deaths
,
heart

attacks
and
strokes
by 20% compared with standard treatment with statin drugs

A 15% reduction in the risk of the
extended

MACE

composite

endpoint
was seen, which included hospitalisation for unstable angina, coronary revascularisation, heart attack, stroke or cardiovascular death.
Repatha reduced the rate of
heart attacks

by 27% and
stroke
by 21%
It reduced
stents and heart bypass
procedures by
22%
Buzz cloud associated with Amgen and Repatha at ACC
Full transcript